Sensory receptor signaling: 5 common errors in neural mapping

In both cases, the mistake is the same: treating a map of expression as a map of function.

That distinction matters as spatial transcriptomics and single-cell sequencing make it easier to locate receptor transcripts across tissues and cell states. More precise maps are useful, but they do not answer every biological question. They cannot, by themselves, show whether a receptor is active, what signal it uses, or whether it contributes to neural wiring. Five recurring errors arise when those questions are collapsed into one.

1. The Fallacy of Random Distribution: Rethinking Nasal Sensory Topography

The familiar picture of the olfactory epithelium is tidy: an olfactory sensory neuron (OSN) chooses one receptor, and neurons expressing the same receptor send their axons to matching glomeruli. In that picture, the neuron’s position in the epithelium is almost incidental. Receptor identity does the explanatory work.

That is an appealing shortcut, but it can flatten real spatial organization. In the mammalian olfactory epithelium, receptor expression is associated with spatially structured zones and gradients rather than an undifferentiated scatter. Developmental signals, including retinoic-acid-related patterning, help shape this organization. The implication is not that receptor position alone determines a neuron’s target. It is that position can be part of the information available to a developing system.

This matters when interpreting a projection map. If the analysis keeps receptor identity but discards where the expressing neurons sit, it may miss a variable relevant to axon guidance. Conversely, a spatial pattern in receptor expression does not prove that the same pattern directly instructs targeting. Expression, developmental context, and axon behavior have to be considered together.

A receptor map is not just a list of identities. It is a list of identities at coordinates; discard the spatial axis and you may discard part of the signal.

For zebrafish work, the principle is useful without assuming that every mammalian spatial pattern has a direct equivalent in the fish. The relevant question is what organization the data actually show in the tissue and developmental stage under study. Spatial assays can help distinguish broad distributions from localized expression, but the pattern should be described from the observed data rather than borrowed from another model.

The practical point is modest but consequential: build spatial coordinates into the analysis from the beginning. Do not treat them as decorative context to add after the projection model is already settled. Then test whether the observed organization predicts anything about neuronal identity, development, or targeting. A map can motivate that experiment; it cannot replace it.

2. Ectopic Receptor Expression: Distinguishing Homeostatic Roles from Sensory Processing

Finding an olfactory-receptor transcript in heart, liver, kidney, or another non-olfactory tissue is interesting. It is not, on its own, evidence for a new sensory circuit.

The temptation is understandable. A receptor with a familiar sensory name turns up in an unexpected cell type, and the result seems to invite a neural explanation. But receptor expression and sensory perception are not interchangeable. Receptors from chemosensory families can be expressed outside their canonical sensory organs, where they may participate in local homeostatic, metabolic, or developmental processes. A receptor in a hepatocyte does not thereby make the hepatocyte an olfactory neuron.

The word expressed carries a narrower meaning than it is often asked to bear. A transcript indicates that the gene’s RNA was detected under particular conditions. It does not establish that the receptor protein is present at the cell surface, that it responds to a particular ligand, or that its activity is connected to a neural circuit. Even convincing evidence of receptor activity would still leave open what that activity does in the local tissue.

So the next step is not to draw an axon where none has been shown. It is to establish function in context. Does changing receptor activity alter a relevant cellular response? Is there evidence for a local ligand or a ligand-independent mechanism? Does the effect depend on the receptor rather than a correlated change in cell state? Those questions distinguish a plausible functional role from a sensory-mapping claim.

The same caution applies when interpreting broad transcriptomic surveys. A detected receptor may be worth following up, but a list of receptor-positive tissues is not a list of new sensory systems. Start with the tissue’s biology and ask what the receptor could be doing there. Only then decide whether a neural mapping framework is appropriate.

3. Beyond Canonical Signaling: Alternative Pathways in Non-Sensory Tissues

In olfactory sensory neurons, the canonical signaling sequence is a useful reference: odorant receptors couple to Golf, activate adenylyl cyclase, raise cyclic AMP, and influence cyclic-nucleotide-gated channels. The pathway is well suited to the job of converting odorant detection into neuronal activity.

It is not a universal definition of what an olfactory receptor must do. When a receptor is expressed in a non-sensory cell, the cellular machinery around it may differ. The receptor may signal through a pathway shaped by that cell’s proteins and physiological role. Looking only for the familiar olfactory cascade can therefore produce a false negative: no canonical components detected, so no functional receptor inferred.

One example described in the literature involves the receptor OR1A1, also known as Olfr43 in the relevant model, in hepatocytes. Its reported effects involve a PKA–CREB–HES1 pathway and are associated with regulation of PPAR-gamma and lipid accumulation. The point is not that this pathway should be expected in every tissue or for every receptor. It is that receptor activity can be routed through cellular mechanisms quite different from the canonical olfactory transduction sequence.

That changes how a negative signaling result should be framed. If the only readout is cyclic AMP, the experiment answers whether that readout changed under those conditions. It does not rule out every possible form of receptor activity. A sound follow-up is guided by the tissue and hypothesis, not by an indiscriminate search for every pathway in the cell.

Depending on the system, useful complementary measurements might include downstream kinase activity, transcriptional responses, or a cell-specific functional phenotype. The appropriate readout should be justified by the biology. A generic panel can generate signals that are difficult to interpret; a focused set of assays can test whether receptor perturbation changes a predicted response.

The distinction also matters for claims about GPCR signaling defects. A change in a downstream pathway is not automatically proof that the receptor is responsible. Receptor-specific perturbation, suitable controls, and a rescue or other orthogonal test can help separate a receptor-dependent effect from the many other ways a cell’s signaling state can change.

4. Transcriptomic Misinterpretation: Cell-State Changes Are Not Neural Maps

Bulk transcriptomics and single-cell RNA sequencing are powerful ways to describe expression. Neither method, by itself, demonstrates that a receptor participates in an active sensory circuit.

A common interpretive leap begins with a comparison between healthy and diseased tissue. A receptor transcript is more abundant in one condition, and the change is taken as evidence for altered sensory mapping. But disease can change the composition and state of a tissue. Tumor progression, inflammation, stress, or altered differentiation may shift gene expression without creating a sensory function. The receptor may be part of a broader cell-state change rather than a driver of neural organization.

This is not a reason to dismiss an unexpected transcript. It is a reason to keep the claim proportional to the evidence. Expression data can identify a candidate and suggest a hypothesis. They cannot establish receptor protein localization, ligand response, neuronal connectivity, or perceptual consequence without additional evidence.

A useful interpretation separates the questions rather than letting one stand in for another:

1. Is the transcript reliably detected? Check that the signal is not explained by technical artifacts, low-quality cells, or a change in the mixture of cell types.

2. Which cells express it? A tissue-level increase may reflect more receptor-expressing cells rather than increased expression within a particular cell type.

3. Does receptor perturbation change a functional readout? Calcium imaging, electrophysiology, or a relevant downstream assay may help, depending on the proposed mechanism.

4. Does the effect fit a neural model? Evidence of expression or cellular signaling does not establish a connection to a sensory circuit.

5. Does the result hold in an appropriate second system? A follow-up model should match the biological question, not merely be convenient.

Zebrafish can be valuable for studying sensory development and activity in vivo, but the model is not a shortcut around validation. An imaging experiment should test a defined functional prediction, and conclusions should stay within what the assay can show. A change in neural activity, for instance, does not by itself identify which receptor caused it or establish how the receptor is coupled.

For work on sensory processing disorders mechanisms, that separation is especially important. Disease-associated expression changes may point toward a mechanism, but they do not yet reveal whether the mechanism is sensory, neural, or part of a more general shift in cell state. The distinction is not pedantic. It determines what experiment comes next.

5. Refining Axon Targeting Models: The Role of Agonist-Independent Baseline Activity

A simple account of olfactory axon targeting gives receptor signaling a role in guiding OSN axons toward appropriate glomeruli. The model becomes incomplete, however, if it assumes that receptor activity begins only when an odorant binds.

Some olfactory receptors can show agonist-independent baseline activity. In developing OSNs, this activity has been linked to cyclic-AMP-dependent signaling and to regulation of axon-guidance molecules, including Neuropilin-1 (Nrp1) and Plexin-A1 (PlxnA1). These molecules contribute to axonal guidance, including along the anterior–posterior axis. The developmental implication is that receptor signaling may influence wiring before odorant-evoked sensory responses become the relevant explanation.

This makes two experiments that can look similar on paper biologically different. Eliminating receptor expression removes both ligand-dependent signaling and any baseline activity associated with the receptor. Disrupting ligand binding, by contrast, may leave some baseline signaling intact. If those manipulations produce different targeting phenotypes, the difference is not a nuisance to average away; it may be the clue to how the receptor contributes.

That does not mean every receptor has the same baseline activity or that baseline signaling alone specifies a target. The point is to make the distinction experimentally visible. When testing a receptor’s role in axon guidance, separate loss of expression from loss of ligand responsiveness where the model allows it. Measure the relevant developmental and guidance readouts, and avoid interpreting one perturbation as a complete stand-in for the other.

A receptor may signal before an odorant arrives. A targeting model that waits for ligand binding can miss part of development.

Reading the map without asking it to do everything

These five errors share a common source: allowing one kind of evidence to answer a different kind of question. Spatial expression is not a complete wiring diagram. Ectopic expression is not proof of sensory perception. A canonical pathway is not the only possible route to receptor activity. Transcript changes do not establish circuit function. And ligand binding is not necessarily the beginning of receptor signaling during development.

The remedy is not simply to collect more data. It is to state precisely what each dataset establishes, then choose the next experiment to test what remains uncertain. A spatial map can reveal organization. A perturbation can test receptor dependence. A functional assay can examine signaling. Evidence for connectivity and sensory processing requires its own support.

That is a more demanding way to tell the story, but it is also a sturdier one. Receptors can occupy unexpected places and do unexpected work. The interpretation becomes convincing not when the map looks complete, but when expression, mechanism, and function have each been shown to carry their part of the explanation.